Half-year report · HY
2689.TEDINET S100XKW2
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥674m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥695m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥48.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.2bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥772m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥977m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥76.02 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 25.3% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥68m |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥114,000 |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥122m |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥58.9bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥58.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥900m |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥555m |
| SPDreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥66m |
| SPDreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥64m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥63.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥62.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥966m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥742m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 1460155000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 62444669000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 62444669000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 900266000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 65827000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 114000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 966208000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -966208000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 58922617000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 3027989000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 1460270000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 63410877000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -966208000 | JPY |
| Net sales | InterimDuration | 62444669000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 555164000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 64325000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 122360000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 741851000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -68251000 | JPY |
| Operating income | InterimDuration | 673599000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)中国財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-02-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第77期中(自 2025年７月１日 至 2025年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | ＯＬＢＡ ＨＥＡＬＴＨＣＡＲＥ ＨＯＬＤＩＮＧＳ，Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 前島 洋平 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 日本生命岡山第二ビル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02928 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 26890 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | OLBA HEALTHCARE HOLDINGS, INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |